Online Program

286797
Disparities in prostate cancer treatment selection in the state of Florida: The impact of socioeconomic status and education level


Tuesday, November 5, 2013 : 9:30 a.m. - 9:45 a.m.

Donald Parris, PhD, CCRC, Center for Research and Grants, Baptist Health South Florida, Coral Gables, FL
Noella A. Dietz, PhD, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL
Edward Trapido, Sc.D, F.A.C.E., Epidemiology Program, Louisiana State University Health Sciences Center, School of Public Health, New Orleans, LA
David J. Lee, PhD, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL
Tulay Koru-Sengul, MHS, PhD, Department of Public Health Sciences, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
Background: Disparities exist in the initial treatment selected by a patient and his provider for the treatment of localized prostate cancer (LPC). The objective of this study was to examine the impact of socioeconomic status (SES) and education level (EL) on initial treatment selection of LPC after controlling for sociodemographic and clinical factors. Methods: The Florida Cancer Data System was used to obtain data (n=85,062) from men diagnosed with LPC between 2001 and 2009. Initial treatments were surgery (34%), radiation (32%), hormonal (22%) or watchful waiting (WW) (12%). US Census data was used to construct area-based socioeconomic measures of education and SES at the census-tract level. Univariate and multivariate polytomous logistic regression models were fitted to initial treatment with SES and EL as main predictors. The models were further adjusted for age at diagnosis, race/ethnicity, marital, smoking and insurance status, urban/rural residence and tumor grade. Results: Compared to those with a greater than a high school education, men with less than a high school education were less likely to choose surgery (OR:0.76;95%CI:0.71–0.81) or radiation (OR:0.77;95%CI:0.72–0.82) over WW. This observation was also true when comparing men with highest (OR:0.69;95%CI:0.64–0.75) and lowest (OR:0.72;95%CI:0.66–0.76) SES. In the adjusted models these associations remained for SES. Conclusions: After controlling for sociodemographic and clinical factors, there was a significant association between SES and initial treatment selection for LPC. With no gold standard for LPC treatment, it is important to understand the factors associated with a patient's initial treatment selection and their impact on health outcomes.

Learning Areas:

Epidemiology
Public health or related research

Learning Objectives:
Identify disparities in prostate cancer treatment selection related to sociodemographic factors.

Keyword(s): Cancer, Social Class

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have over 14 years of experience conducting health related research in various settings with diverse populations. The desire to use and combine data in innovative ways to improve health related outcomes has been the driving force throughout my training and professional career. My research interests include outcomes research and disparities research.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.